In addition to accelerating cancer progression, deletion of the Foxp1-Shq1 locus with Pten loss results in changes in signaling, such as mTORC1 activation and restored nuclear hormone receptor activity, that are mirrored in human prostate cancers with comparable genotypes. This evidence concerns the gene PTEN and prostate cancer.